Daily non-political popular news in brief.
Existing drugs show promise for treating end-stage renal disease in lupus
11-09-2007 · EurekAlert!Studies in mice suggest that two drugs already approved by the US Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, MD, in presentations this week at the American College of Rheumatology in Boston.
Read more »
Keywords: existing, drugs, show, promise, treating, end-stage, renal, disease, lupus, drug, end, stage, lupu
« Previous | Next »
Similar news on "Existing drugs show promise for treating end-stage renal disease in lupus":
- Experimental drug boosts survival in recurrent ovarian cancer
09-27-2007 · EurekAlert!
An experimental drug has shown promise in extending the survival period for women with recurrent ovarian cancer whose treatment options have dwindled. Early testing data showed that pertuzumab added weeks to the lives of Stage 3 ovarian cancer patients whose disease had returned after treatment with existing chemotherapy, said a researcher from the University of Alabama at Birmingham.
Similar news · Read more »
- Tequila raw ingredient being developed into drug-carrier that targets colon diseases
03-27-2007 · EurekAlert!
Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
Similar news · Read more »
- New type of drug shows promise in attacking melanoma in an innovative way
09-26-2007 · EurekAlert!
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. New research presented today at the European Cancer Conference in Barcelona found that giving the new drug in addition to chemotherapy more than doubled the amount of time patients survived without progression of their cancer.
Similar news · Read more »
- New alzheimer's drug shows promise in clinical trial
11-02-2006 · EurekAlert!
The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease.
Similar news · Read more »
- Prescribing information for kidney disease far too vague
12-06-2006 · EurekAlert!
Prescribing information for healthcare professionals treating patients with kidney disease is too vague, concludes the latest issue of Drug and Therapeutics Bulletin (DTB). Many of the 4-5 percent of the UK population with serious chronic kidney disease are elderly people, who are often taking several different drugs. Other risk factors for the disease include diabetes and high blood pressure.
Similar news · Read more »
- For treating advanced Parkinson's, new research points to serotonin
02-04-2008 · EurekAlert!
Studies in a mouse model of Parkinson's disease show that side effects caused by repeated use of the drug L-DOPA can be minimized by blocking the serotonin 1B receptor. The finding, reported by researchers at Rockefeller University and the Karolinska Institute, suggests that targeting the 1B receptor may provide an alternative approach for treating advanced Parkinson's disease.
Similar news · Read more »
- Stem cells show promise for treating Huntington's disease
09-25-2007 · EurekAlert!
Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease. Scientists used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington’s, generating new medium spiny neurons -- the cell lost in Huntington's disease.
Similar news · Read more »
- Discovery of an HIV inhibitor in human blood points to new drug class
04-19-2007 · EurekAlert!
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
Similar news · Read more »
- Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
05-30-2007 · EurekAlert!
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.
Similar news · Read more »
- Memantine and Alzheimer's disease
01-10-2008 · EurekAlert!
In a study published in the Journal of Alzheimer's Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer's disease and praised as "the first and only representative of a new class of Alzheimer drugs" works in fact similar to other existing compounds, and is beneficial only in a narrow concentration range. They further indicate that the complex pharmacological profile of memantine requires careful consideration concerning suitable doses and suitable patient groups.
Similar news · Read more »
